Literature DB >> 31308185

Palliative TACE for hepatic metastases of chromophobe renal cell carcinoma.

Peter D Whooley1, John Paul Flores2, Mehran Fotoohi3, Bruce S Lin2.   

Abstract

We describe the case of a man with chromophobe renal cell carcinoma (chRCC) and numerous metastatic lesions restricted to the liver. Despite extensive courses of various systemic targeted chemotherapies, progressive disease was noted on CT and MRI and the patient suffered from persistent abdominal pain associated with his metastatic lesions. The liver lesions and associated symptoms were effectively palliated with serial transarterial chemoembolisation (TACE). While it is unclear if TACE has impacted his overall survival, this case encourages the use of TACE for palliative intent for patients with metastatic chRCC. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cancer intervention; interventional radiology; oncology; pain (palliative care); urological cancer

Mesh：

Year:  2019        PMID： 31308185      PMCID： PMC6663226          DOI： 10.1136/bcr-2019-229207

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  26 in total

1.  Uveal Melanoma Metastatic to the Liver: Chemoembolization With 1,3-Bis-(2-Chloroethyl)-1-Nitrosourea.

Authors:  Carin F Gonsalves; David J Eschelman; Bartley Thornburg; Andrea Frangos; Takami Sato
Journal:  AJR Am J Roentgenol       Date:  2015-04-23       Impact factor: 3.959

2.  Transarterial chemoembolisation (TACE) with gemcitabine: phase II study in patients with liver metastases of breast cancer.

Authors:  Katrin Eichler; Silke Jakobi; Tatjana Gruber-Rouh; Renate Hammerstingl; Thomas J Vogl; Stephan Zangos
Journal:  Eur J Radiol       Date:  2013-09-01       Impact factor: 3.528

3.  Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology.

Authors:  Robert J Motzer; Jennifer Bacik; Tania Mariani; Paul Russo; Madhu Mazumdar; Victor Reuter
Journal:  J Clin Oncol       Date:  2002-05-01       Impact factor: 44.544

4.  Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.

Authors:  Alessandro Volpe; Giacomo Novara; Alessandro Antonelli; Roberto Bertini; Michele Billia; Giorgio Carmignani; Sergio Cosciani Cunico; Nicola Longo; Guido Martignoni; Andrea Minervini; Vincenzo Mirone; Alchiede Simonato; Carlo Terrone; Filiberto Zattoni; Vincenzo Ficarra
Journal:  BJU Int       Date:  2011-11-01       Impact factor: 5.588

5.  Transarterial chemoembolization in soft-tissue sarcoma metastases to the liver - the use of imaging biomarkers as predictors of patient survival.

Authors:  Julius Chapiro; Rafael Duran; MingDe Lin; Benedetto Mungo; Todd Schlachter; Rüdiger Schernthaner; Boris Gorodetski; Zhijun Wang; Jean François Geschwind
Journal:  Eur J Radiol       Date:  2014-12-13       Impact factor: 3.528

6.  Cancer statistics, 2016.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-01-07       Impact factor: 508.702

7.  Liver metastases: neoadjuvant downsizing with transarterial chemoembolization before laser-induced thermotherapy.

Authors:  Thomas J Vogl; Martin G Mack; Jörn O Balzer; Kerstin Engelmann; Ralf Straub; Katrin Eichler; Dirk Woitaschek; Stephan Zangos
Journal:  Radiology       Date:  2003-09-18       Impact factor: 11.105

Review 8.  The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.

Authors:  Holger Moch; Antonio L Cubilla; Peter A Humphrey; Victor E Reuter; Thomas M Ulbright
Journal:  Eur Urol       Date:  2016-02-28       Impact factor: 20.096

9.  Repetitive transarterial chemoembolization (TACE) of liver metastases from gastric cancer: local control and survival results.

Authors:  Thomas J Vogl; Tatjana Gruber-Rouh; Katrin Eichler; Nour-Eldin A Nour-Eldin; Jörg Trojan; Stephan Zangos; Nagy N N Naguib
Journal:  Eur J Radiol       Date:  2012-11-03       Impact factor: 3.528

10.  Intra-arterial therapy of neuroendocrine tumour liver metastases: comparing conventional TACE, drug-eluting beads TACE and yttrium-90 radioembolisation as treatment options using a propensity score analysis model.

Authors:  Duc Do Minh; Julius Chapiro; Boris Gorodetski; Qiang Huang; Cuihong Liu; Susanne Smolka; Lynn Jeanette Savic; David Wainstejn; MingDe Lin; Todd Schlachter; Bernhard Gebauer; Jean-François Geschwind
Journal:  Eur Radiol       Date:  2017-07-04       Impact factor: 5.315
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.